Alpha 2.0
Login Register
» Authors » Kehang Liu

Kehang Liu

Explore the profile of Kehang Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 47
Followers 0
Related Specialties
Biology
Pharmacology
Chemistry
Top 10 Co-Authors
Yuqing Chen
Huidan Zhang
Xixi Xu
Yangke Wanyan
Tongtong Lv
Yunqing Yang
Junai Zhen
Zhihai Chen
Zhouling Jiang
Xiaoyu Xue
Published In
Front Pharmacol
Molecules
PLoS Negl Trop Dis
Drug Des Devel Ther
Cell Death Discov
Affiliations
Soon will be listed here.
Recent Articles
1.
Early therapy contributes to the normalization of platelet in patients with severe fever with thrombocytopenia syndrome during the convalescent phase
Xue X, Wang X, Lin L, Niu W, Jiang Z, Liu K, et al.
PLoS Negl Trop Dis . 2025 Jan; 19(1):e0012793. PMID: 39804937
Background: Platelet recovery was an important prognostic indicator in severe fever with thrombocytopenia syndrome (SFTS). This study focused on risk factors affecting platelet recovery in surviving SFTS patients, which can...
2.
Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
Mu Y, Wu H, Jiang Z, Liu K, Xue X, Zhang W, et al.
Vaccines (Basel) . 2023 Jul; 11(7). PMID: 37514946
The humoral immune response and safety of the fourth dose of the coronavirus disease 2019 (COVID-19) vaccine in solid organ transplant (SOT) recipients need to be fully elucidated. We conducted...
3.
Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)D in hepatocellular carcinoma
Zhang H, Zhen J, Zhang R, Wanyan Y, Liu K, Yuan X, et al.
Cell Death Discov . 2022 Jan; 8(1):27. PMID: 35039485
Cathelicidin hCAP18/LL-37 can resist infection from various pathogens and is an essential component of the human immune system. Accumulating evidence has indicated that hCAP18/LL-37 plays a tissue-specific role in human...
4.
2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors
Wanyan Y, Xu X, Liu K, Zhang H, Zhen J, Zhang R, et al.
Molecules . 2020 Dec; 25(23). PMID: 33297583
Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential...
5.
Effect of Hydrophobicity on the Anticancer Activity of Fatty-Acyl-Conjugated CM4 in Breast Cancer Cells
Yang Y, Zhang H, Wanyan Y, Liu K, Lv T, Li M, et al.
ACS Omega . 2020 Sep; 5(34):21513-21523. PMID: 32905373
Antimicrobial peptides (AMPs) are important anticancer resources, and exploring AMP conjugates as highly effective and selective anticancer agents would represent new progress in cancer treatment. In this study, we synthesized...
6.
Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis and/or apoptosis pathway
Zhang H, Han D, Lv T, Liu K, Yang Y, Xu X, et al.
Drug Des Devel Ther . 2019 Jul; 13:2153-2167. PMID: 31308628
There is an urgent need for the development of novel, effective, and less toxic drugs to treat leukemia. Antimicrobial peptides (AMPs) have received much more attention as alternative chemotherapeutic agents....
7.
N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
Li C, Liu H, Yang Y, Xu X, Lv T, Zhang H, et al.
Front Pharmacol . 2018 Nov; 9:1297. PMID: 30483133
Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by...